Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Alteogen will participate in the “2024 K-Bio Insight Forum” held at Lotte Hotel Jeju from March 6 to March 8, 2024, to present its pipeline progress and conduct Q&A sessions for domestic and international healthcare industry participants and institutional investors.
📊 [Key Disclosure Details & Financial Highlights]
- Event Date & Time: March 6, 2024 ~ March 8, 2024
- March 6: 13:30 – 17:30
- March 7: 09:00 – 17:30
- March 8: 09:00 – 13:00
- Venue & Sponsor: Lotte Hotel Jeju / Hosted by The Korea Economic Daily
- Target Audience: Domestic/international pharma/bio/healthcare industry personnel, institutional investors (VCs), strategic investors, government officials (Ministry of Health and Welfare, etc.)
- Purpose: Sharing R&D achievements and industry outlook, networking with industry participants and global pharma companies, exploring new business opportunities
- Format/Method: Participation as a presenting company at the “2024 K-Bio Insight Forum”
- Key Agenda: Presentation on company pipeline progress and Q&A
- Date of Confirmation: 2024-02-15
- Contact Department: IR Group (Manager Sigyun Park) / Tel: +82-42-384-8780
- IR Material Posting Date & Location: Scheduled for March 6, 2024, on the Korea Exchange KIND website (http://kind.krx.co.kr)
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Why Verifying IR Material Publication and Pipeline Status Disclosures Is Necessary
This filing is an informational disclosure notifying the schedule and presentation publication plans for participating in an industry forum IR session targeting institutional investors and industry stakeholders.
Checking this follow-up item is necessary because confirming that the official IR presentation material is published on the Korea Exchange KIND website according to the announced date (March 6, 2024) is essential. Verifying that the corporate presentation materials disclosing pipeline progress are properly posted on the specified release date ensures the final verification of the disclosed facts.
The presentation materials can be verified on the Korea Exchange KIND website (http://kind.krx.co.kr) or through future related filings on DART.
📢 Disclaimer & Source Information
Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).
Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.
